Stocks and Investing Stocks and Investing
Wed, October 2, 2019
Tue, October 1, 2019
Mon, September 30, 2019

David Novak Upgraded (ZYME) to Strong Buy and Increased Target to $40 on, Sep 30th, 2019


Published on 2024-10-26 16:32:24 - WOPRAI, David Novak
  Print publication without navigation


David Novak of Raymond James, Upgraded "Zymeworks Inc." (ZYME) to Strong Buy and Increased Target from $36 to $40 on, Sep 30th, 2019.

David has made no other calls on ZYME in the last 4 months.



There are 3 other peers that have a rating on ZYME. Out of the 3 peers that are also analyzing ZYME, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $23 on, Monday, August 5th, 2019


These are the ratings of the 2 analyists that currently disagree with David


  • Stephen Willey of "Stifel" Initiated at Strong Buy and Held Target at $45 on, Friday, August 30th, 2019
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $49 on, Tuesday, August 27th, 2019

Contributing Sources